Selected
Health in Fragile Contexts Challenge

SURAKSHA™ by Briota Technologies

Briota uses artificial intelligence (AI) and the Internet of things (IoT) to enable early precise diagnosis of Chronic Respiratory Diseases (COPD, ILD, Post TB, Long Covid, Asthma) in resource constrained settings.

Team Leader
Gajanan Sakhare
Briota SURAKSHA™ is an AI-enabled point-of-care platform that delivers rapid, integrated 14-biomarker NCD screening with real-time risk stratification in a single visit.

Solution Pitch 

The Problem

Globally, about 750 million people have Asthma, COPD, Post TB Lung Impairment and more than 75% of these cases are undiagnosed, causing huge economic burdens and premature deaths. Pulmonary function (PFT) test costs, unavailability of trained technicians, and absence of pulmonologists are major factors for late or missing diagnosis at the primary care level.

The Solution

Briota's solution SAVE™ (Screening Assisted Virtually and Early), is an affordable and scalable alternative to expensive Pulmonary Function Tests mostly performed in secondary or tertiary care settings. Briota's innovative No Contact AI solution "PFT In A Box™" - Pulmonary Function Test is India's first and only Point of Care Diagnostics with Spirometer, Impulse Oscillometer and GOLD standard Clinical Diagnostic Support System. 

Apart from COPD and Asthma, Project SAVE™ using Briota's unique point of care AI first platform SURAKSHA (Save) is now expanded to cover other difficult to diagnose conditions in primary healthcare settings. These conditions include Cardiometabolic diseases and Common cancers - Lungs, Breast and Oral

Stats

  • Project SAVE™ has, to date, helped 55,000 patients in various states in India who were assisted by SAVE™ technology of early screening, diagnosis and escalation for chronic respiratory conditions including Covid, Asthma, COPD and post TB lung impairment.

Market Opportunity

The organization’s primary focus is in India followed by other countries in Asia and Africa. As part of the National Program on NCD, the SAVE™ solution has a potential market value of  $500 million in primary care settings. Similar and larger markets in primary care exist in Asia and Africa and the team has presented its solution in Bangladesh, Nepal, and the Philippines.

Organization Highlights

SAVE by Briota Technologies has current partnerships with:

  • National Health Mission, Government of India: part of the National Program for NCD.
  • Mahatma Phule Backward Class Development Corporation, Mumbai India: for training the backward class youth as PFT technicians.
  • Aarhus University Hospital, Denmark: Research and Clinical validation of its solutions in European settings.

Partnership Goals

SAVE seeks assistance in establishing sales and implementation partnerships to start with small pilots for establishing SOP’s in Asian and African countries.

What is the name of your organization?
Briota Technologies Pvt Ltd
What is the name of your solution?
SURAKSHA™ by Briota Technologies
Provide a one-line summary or tagline for your solution.
Briota SURAKSHA™ is an AI-enabled point-of-care platform that delivers rapid, integrated 14-biomarker NCD screening with real-time risk stratification in a single visit.
In what city, town, or region is your solution team headquartered?
Pune
In what country is your solution team headquartered?
India
What type of organization is your solution team?
For-Profit
Film your elevator pitch.
What specific problem are you solving?
Non-communicable diseases (NCDs) cause most global deaths, yet early screening remains inaccessible and fragmented. Patients must undergo multiple costly tests, often resulting in delayed diagnosis and advanced complications. Limited primary care infrastructure further restricts preventive care. Affordable, integrated, point-of-care screening is urgently needed to enable early risk detection and intervention.
What is your solution?
Briota SURAKSHA™ is an AI-enabled point-of-care testing (POCT) platform designed to deliver comprehensive screening for 14 non-communicable disease (NCD) biomarkers in a single visit. The portable system integrates multi-analyte diagnostics with automated, cloud-connected AI risk stratification to assess cardiometabolic, renal, and related chronic disease risks within minutes. By consolidating multiple laboratory tests into one streamlined workflow, SURAKSHA™ reduces cost, time, and infrastructure requirements, making preventive screening feasible in primary care clinics, community health settings, workplaces, and outreach programs. The platform generates instant digital reports with actionable risk insights, enabling providers to initiate early lifestyle, medical, or referral interventions. Its interoperable data architecture supports population-level analytics while maintaining patient privacy. Designed for use by trained frontline providers rather than specialists, SURAKSHA™ democratizes access to advanced diagnostics and shifts NCD detection from centralized laboratories to decentralized community-based care environments.
Who does your solution serve, and in what ways will the solution impact their lives?
SURAKSHA™ enables a systemic shift from late-stage disease management to early risk identification and prevention. By detecting NCD risks before symptoms escalate, the platform reduces preventable complications such as heart attacks, kidney failure, COPD, and diabetes-related morbidity. Early identification supports timely clinical intervention, improving long-term outcomes and lowering hospitalization rates and catastrophic health expenditures. For health systems, consolidated screening improves efficiency, reduces diagnostic fragmentation, and generates real-time population risk insights to guide targeted interventions and policy planning. Employers and insurers benefit from healthier populations and reduced productivity losses linked to chronic disease. At the community level, SURAKSHA™ expands equitable access to high-quality preventive screening, particularly for populations with limited laboratory access. Over time, widespread deployment can reduce national NCD burden, ease pressure on tertiary care facilities, and create sustainable, prevention-focused healthcare ecosystems grounded in data-driven decision-making.

Organization Type:
For-profit, including B-Corp or similar models

Headquarters:
Pune, India

Stage:
Growth

Working In:
India

Current Employees:
24

Solution Website:
www.briota.co

Solution Socials:
Twitter
Instagram
Facebook
LinkedIn

Solution Team:
Gajanan Sakhare
Gajanan Sakhare
Founder
Shardul Joshi
Shardul Joshi
Cofounder & CTO
Aditi Pais
Aditi Pais
Chief of Operations - SURAKSHA for Women